Linda Feldbrügge Selected Research

ectoATPase

8/2020	Ecto-Nucleotide Triphosphate Diphosphohydrolase-2 (NTPDase2) Deletion Increases Acetaminophen-Induced Hepatotoxicity.
1/2018	Distinct roles of ecto-nucleoside triphosphate diphosphohydrolase-2 (NTPDase2) in liver regeneration and fibrosis.
9/2017	Expression of Ecto-nucleoside Triphosphate Diphosphohydrolases-2 and -3 in the Enteric Nervous System Affects Inflammation in Experimental Colitis and Crohn's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda Feldbrügge Research Topics

Disease

7	Inflammation (Inflammations) 12/2018 - 01/2011
6	Fibrosis (Cirrhosis) 06/2021 - 01/2016
5	Liver Cirrhosis (Hepatic Cirrhosis) 08/2020 - 01/2016
4	Neoplasm Metastasis (Metastasis) 04/2022 - 01/2019
3	Stomach Neoplasms (Stomach Cancer) 04/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2019
2	Colitis 11/2018 - 09/2017
2	Crohn Disease (Crohn's Disease) 11/2018 - 09/2017
2	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2016
2	Sepsis (Septicemia) 10/2017 - 10/2017
2	Ischemia 01/2011 - 01/2010
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Peritoneal Neoplasms 01/2022
1	Postoperative Hemorrhage 09/2021
1	Postoperative Pain 09/2021
1	Hepatitis 05/2020
1	Leukocytosis (Pleocytosis) 05/2020
1	Neoplasms (Cancer) 01/2019
1	Hypoxia (Hypoxemia) 11/2018
1	Cholangiocarcinoma 07/2018
1	Delirium 10/2017
1	Brain Injuries (Brain Injury) 10/2017
1	Fatty Liver 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016
1	Heart Diseases (Heart Disease) 01/2011
1	Post-Cardiac Arrest Syndrome 01/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2010

Drug/Important Bio-Agent (IBA)

3	ectoATPaseIBA 08/2020 - 09/2017
3	NucleosidesIBA 12/2018 - 09/2017
2	CollagenIBA 01/2019 - 01/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 10/2017
2	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2019 - 01/2018
2	EnzymesIBA 01/2018 - 09/2017
2	NucleotidesIBA 01/2018 - 10/2017
2	triphosphoric acid (triphosphate)IBA 01/2018 - 09/2017
2	Adenosine Triphosphate (ATP)IBA 10/2017 - 12/2014
2	Purinergic P2X7 ReceptorsIBA 10/2017 - 10/2017
2	CytokinesIBA 10/2017 - 10/2017
2	nasIBA 03/2016 - 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	sodium thiosulfate FDA Link 01/2022
1	Cell-Free Nucleic AcidsIBA 05/2020
1	C-Reactive ProteinIBA 05/2020
1	AerosolsIBA 01/2020
1	RamucirumabIBA 01/2020
1	Coffee FDA Link 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	Purinergic P1 Receptor AntagonistsIBA 01/2019
1	BilirubinIBA 11/2018
1	Ritonavir (Norvir)FDA Link 11/2018
1	LigandsIBA 11/2018
1	XenobioticsIBA 11/2018
1	Therapeutic UsesIBA 11/2018
1	Dextran SulfateIBA 11/2018
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2018
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 11/2018
1	AngiopoietinsIBA 07/2018
1	Biomarkers (Surrogate Marker)IBA 07/2018
1	MicroRNAs (MicroRNA)IBA 07/2018
1	Adenosine DeaminaseIBA 01/2018
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2018
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2017
1	Apyrase (ATP Diphosphatase)IBA 09/2017
1	SodiumIBA 09/2017
1	Dextrans (Dextran)FDA Link 09/2017
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Keratin-18 (Keratin 18)IBA 01/2016
1	VLDL LipoproteinsIBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Adenosine Diphosphate (ADP)IBA 12/2014
1	Annexin A5IBA 01/2011

Therapy/Procedure

3	Hyperthermic Intraperitoneal Chemotherapy 04/2022 - 06/2021
3	Cytoreduction Surgical Procedures 04/2022 - 06/2021
3	Liver Transplantation 06/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 04/2022 - 01/2020
2	Hepatectomy 12/2020 - 01/2018
2	Ligation 11/2018 - 10/2017
2	Cardiopulmonary Resuscitation (CPR) 01/2011 - 01/2010
2	Resuscitation 01/2011 - 01/2010
1	Combined Modality Therapy 01/2022
1	Length of Stay 09/2021
1	Transplantation 06/2021
1	Therapeutics 01/2020
1	Aftercare (After-Treatment) 01/2019
1	Punctures 10/2017